These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2999402)

  • 1. 3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake.
    Bøgesø KP; Christensen AV; Hyttel J; Liljefors T
    J Med Chem; 1985 Dec; 28(12):1817-28. PubMed ID: 2999402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.
    Hyttel J; Larsen JJ
    J Neurochem; 1985 May; 44(5):1615-22. PubMed ID: 2580950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
    Maryanoff BE; McComsey DF; Gardocki JF; Shank RP; Costanzo MJ; Nortey SO; Schneider CR; Setler PE
    J Med Chem; 1987 Aug; 30(8):1433-54. PubMed ID: 3039136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.
    Bøgesø KP
    J Med Chem; 1983 Jul; 26(7):935-47. PubMed ID: 6134833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
    Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
    J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005.
    Nowak G; Arnt J; Hyttel J; Svendsen O
    J Neural Transm; 1985; 64(3-4):227-38. PubMed ID: 2418155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.
    Arnt J; Christensen AV; Hyttel J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):101-7. PubMed ID: 2409454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
    Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
    J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes.
    Javanmard S; Deutsch HM; Collard DM; Kuhar MJ; Schweri MM
    J Med Chem; 1999 Nov; 42(23):4836-43. PubMed ID: 10579846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals.
    Suarez-Roca H; Cubeddu LX
    J Pharmacol Exp Ther; 2002 Jul; 302(1):174-9. PubMed ID: 12065714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.
    Yu H; Kim IJ; Folk JE; Tian X; Rothman RB; Baumann MH; Dersch CM; Flippen-Anderson JL; Parrish D; Jacobson AE; Rice KC
    J Med Chem; 2004 May; 47(10):2624-34. PubMed ID: 15115403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Raiteri M; Del Carmine R; Bertollini A; Levi G
    Eur J Pharmacol; 1977 Jan; 41(2):133-43. PubMed ID: 832672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine and 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter.
    Carroll FI; Kotian P; Dehghani A; Gray JL; Kuzemko MA; Parham KA; Abraham P; Lewin AH; Boja JW; Kuhar MJ
    J Med Chem; 1995 Jan; 38(2):379-88. PubMed ID: 7830281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
    Carlier PR; Lo MM; Lo PC; Richelson E; Tatsumi M; Reynolds IJ; Sharma TA
    Bioorg Med Chem Lett; 1998 Mar; 8(5):487-92. PubMed ID: 9871604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific inhibitory action of a novel antidepressant paroxetine on 5-HT uptake].
    Tanigaki N; Manno K; Sugihara K; Miki N; Ichida S; Yoshida H
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):175-80. PubMed ID: 3038714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.
    Guiard BP; El Mansari M; Merali Z; Blier P
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):625-39. PubMed ID: 18205979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP; Conarty PF; Nichols DE
    Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.